| CLASS | DRUG/TOX | LP7790-1 |
| COMPONENT | Norverapamil | LP17240-0 |
| PROPERTY | PrThr | LP217195-9 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Ser/Plas | LP7576-4 |
| SCALE_TYP | Ord | LP7751-3 |
| METHOD_TYP | Screen | LP6503-9 |
| parent | Norverapamil | Serum or Plasma | Drug toxicology | LP389301-5 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Both | |
| UNITSREQUIRED | N |
| LONG_COMMON_NAME | en-US | Norverapamil [Presence] in Serum or Plasma by Screen method |
| LONG_COMMON_NAME | en-US | Norverapamil [Presence] in Serum or Plasma by Screen method |
| SHORTNAME | en-US | Norverapamil SerPl Ql Scn |
| ConsumerName | en-US | Norverapamil, Blood |
| SHORTNAME | es-AR | norverapamilo:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal:tamizaje |
| SHORTNAME | pt-BR | Norverapamil SerPl Ql Scn |
| LONG_COMMON_NAME | fr-FR | Norvérapamil [Présence/Seuil] Sérum/Plasma ; Qualitatif ; Dépistage |
| LONG_COMMON_NAME | nl-NL | Norverapamil [aanwezigheid] in serum of plasma d.m.v. screening |
| LONG_COMMON_NAME | es-MX | Norverapamilo: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: Pantalla de toxicología |
LOINC Version: 2.77
FHIR